Skip to content
OpenCapital
Get started

Stoke Therapeutics, Inc. STOK Market capitalization

Market capitalization at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$12.4B+159%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$11.64B+54.4%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$5.55B+116%
Praxis Precision Medicines, Inc. logo
Praxis Precision Medicines, Inc.PRAX
$8.97B+1,075%
Harmony Biosciences Holdings, Inc. logo
Harmony Biosciences Holdings, Inc.HRMY
$1.62B-14.9%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$1.64B+40.1%

Other financials

Income statement

See full
Revenue$6.2M-96.1%
Operating income-$53.4M-148%
Net income-$50.0M-144%
EPS (diluted)-$0.79-142%

Balance sheet

See full
Cash & equivalents$155.7M-43.4%
Total debt$3.4M-42.5%
Total equity$394.9M+12.8%
Total assets$443.3M+8.9%

Cash flow

See full
Operating cash flow-$60.6M-146%
CapEx$353.0K+132%
Free cash flow-$60.9M-146%

Valuation

See full
Enterprise value$1.79B+1,855%
P/S60.4×+58.5×

Profitability

See full
Operating margin-577.5%-597pp
Net margin-529.2%-556pp
FCF margin36.2%+18.4pp

Returns & leverage

See full
Return on equity-45.6%-66.1pp
Debt / equity0×0.0×
Current ratio9×+0.6×

Where this comes from

Computed from the period-end share price: $1.93B.

The official record: Stoke Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stoke Therapeutics, Inc.'s market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Stoke Therapeutics, Inc.'s market capitalization?
Stoke Therapeutics, Inc. (STOK) reported market capitalization of $1.93B in Q1 2026.
How has Stoke Therapeutics, Inc.'s market capitalization changed year-over-year?
Stoke Therapeutics, Inc.'s market capitalization increased by 435.6% year-over-year, from $359.62M to $1.93B.
What is the long-term trend for Stoke Therapeutics, Inc.'s market capitalization?
Over 5 years (2020 to 2025), Stoke Therapeutics, Inc.'s market capitalization has grown at a -4.5% compound annual growth rate (CAGR), from $2.28B to $1.81B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.